Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ZC3H13-Mediated m6A Modification Ameliorates Acute Myocardial Infarction through Preventing Inflammation, Oxidative Stress and Ferroptosis by Targeting lncRNA93358. | Inflammation | 2025 | 39107569 | PubTator, text mining | PubMed |
| RNA Metabolism and the Role of Small RNAs in Regulating Multiple Aspects of RNA Metabolism. | Noncoding RNA | 2024 | 39846679 | PubTator, text mining | PubMed |
| Rapid Detection of PML::RARA Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling. | Biomolecules | 2024 | 39766302 | PubTator, text mining | PubMed |
| Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation. | Epigenetics Chromatin | 2024 | 39623487 | PubTator, text mining | PubMed |
| ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1. | Hum Cell | 2024 | 39614918 | PubTator, text mining | PubMed |
| ZC3H13-induced the m6A modification of hsa_circ_0081723 promotes cervical cancer progression via AMPK/p53 pathway. | J Obstet Gynaecol Res | 2024 | 39476847 | PubTator, text mining | PubMed |
| A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. | Sci Rep | 2024 | 39472491 | PubTator, text mining | PubMed |
| Interplay of RNA m6A Modification-Related Geneset in Pan-Cancer. | Biomedicines | 2024 | 39457524 | PubTator, text mining | PubMed |
| The role of RNA modifications in disease-associated macrophages. | Mol Ther Nucleic Acids | 2024 | 39296330 | PubTator, text mining | PubMed |
| Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes. | Discov Oncol | 2024 | 39292326 | PubTator, text mining | PubMed |
| Structures and mechanisms of the RNA m 6A writer. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39238441 | PubTator, text mining | PubMed |
| ZC3H13 knockdown enhances the inhibitory effect of sevoflurane on gastric cancer cell malignancy by regulating the N6-methyladenosine modification of the lncRNA DLX6-AS1. | Heliyon | 2024 | 39220970 | PubTator, text mining | PubMed |
| Expression patterns and clinical value of key m6A RNA modification regulators in smoking patients with coronary artery disease. | Epigenetics | 2024 | 39167728 | PubTator, text mining | PubMed |
| P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer. | Heliyon | 2024 | 39166030 | PubTator, text mining | PubMed |
| SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma. | Transl Cancer Res | 2024 | 39145091 | PubTator, text mining | PubMed |
| hsa_circ_0101050 regulated by ZC3H13 enhances tumorigenesis in papillary thyroid cancer via m6A modification. | Heliyon | 2024 | 38988519 | PubTator, text mining | PubMed |
| Identification of PATL1 as a prognostic and immunotherapeutic predictive factor for nasal-type natural killer/T-cell lymphoma and head and neck squamous cell carcinoma. | Heliyon | 2024 | 38912458 | PubTator, text mining | PubMed |
| RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations. | Cancers (Basel) | 2024 | 38610981 | PubTator, text mining | PubMed |
| NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma. | Technol Health Care | 2024 | 38517815 | PubTator, text mining | PubMed |
| Arsenic trioxide suppresses lung adenocarcinoma stem cell stemness by inhibiting m6A modification to promote ferroptosis. | Am J Cancer Res | 2024 | 38455419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=4